Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-25

Clinical Trial Update: Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 trial update on ticagrelor in methotrexate-resistant rheumatoid arthritis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TICAGRELOR (ticagrelor)

Snippet

Sponsor: NYU Langone Health | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2021-10-25